Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
ConditionEndometrium Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorIRCCS San Raffaele
About this trial
Endometrial cancer (EC) is the most common gynecological malignancy in high-income countries. Prognosis and treatment are dictated by cancer histological subtype and grade coupled with surgical staging as described by Surgical International Federation of Gynecology and Obstetrics (FIGO) staging system. Surgery is the elective standard treatment and used for staging of EC. The purpose of this study is to collect images from a simultaneous PET/MRI study from which to extrapolate a preoperative, non-invasive, prognostic model.
Eligibility criteria
Qualifiers
histopathological confirmation of a primary endometrial cancer
age > 18 years
no contraindication to surgery (comorbidity, contraindication or lack of consent)
no contraindication to preoperative imaging
Disqualifiers
patients unsuitable for surgical intervention (comorbidity, contraindication or lack of consent, poor performance status)
age < 18 years, c) inability to complete the needed imaging examination (ie, severe claustrophobia)
any additional medical condition that may significantly interfere with study compliance
all the contraindication for MRI (ie, pacemaker).
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov